Reata Pharmaceuticals RETA 深 沪
等待开盘 02-05 09:30:00 美东时间
172.36
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 172.36
- 总市值 65.66亿
- 52周最高 172.46
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 21.83
- 委 比 0.00%
- 总股本 3809.73万
- 历史最高 257.965
- 量 比 0
- 振 幅 0.00%
- 历史最低 11.03
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多华盛早报 | 马斯克迎关键一战！特斯拉Robotaxi今日来袭；11月不降息？美联储官员意外放鹰
今日10点，马斯克迎关键一战！特斯拉Robotaxi震撼来袭；支持11月不降息？美联储官员意外放鹰；因重阳节假期，港股今日休市>>
2024-10-11 08:31
Biogen posts Q2 beat as sales from Alzheimer’s drug pick up
Despite an earnings miss, Biogen (NASDAQ:BIIB) managed to slightly exceed Street forecasts with its Q2 2024 revenue as sales from its newly-approved Alzheimer's drug Leqembi gained momentum while its ...
2024-08-01 20:50
Biogen Completes Acquisition of Reata Pharmaceuticals
Reata acquisition bolsters Biogen's rare disease portfolio with the addition of...
2023-09-26 20:59
Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi
Eisai Co Ltd (OTC: ESALY) (OTC: ESALF) and Biogen Inc (NASDAQ: BIIB) announced that humanized anti-soluble aggregated amyloid-beta (A&be
2023-09-25 22:41
Reata Pharmaceuticals Stockholders Approve Merger Transaction With Biogen Inc.
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) ("Reata," the "Company," "our," "us," or "we"), a global, biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases,
2023-09-21 22:14
全球医药牛股辈出！除了礼来，诺和诺德，这些股也值得拣货
8月至今，减肥药行情爆火，诺和诺德、礼来两大减肥药生产商市值一路飙升，诺和诺德位列欧洲市值第一，礼来市值突破5600亿美元；医药板块牛股频出，下一个暴涨的黑马股是谁？详情>>
2023-09-14 22:54
Is Reata Pharmaceuticals (NASDAQ:RETA) Using Debt In A Risky Way?
Howard Marks put it nicely when he said that, rather than worrying about share ...
2023-09-14 03:29
美股生物医药股如何买？汇丰新鲜名单出炉
本周，汇丰开始对这11家美国生物制药公司的股票进行研究和分析，并将艾昆纬(IQV.US)、Zoetis(ZTS.US)、Blue bird(BLBD.US)和Actinium(ATNM.US)列为其“买入”评级名单。
2023-09-11 10:44
赛诺菲神秘竞购Reata 终败给百健
百健(BIIB.US)以微弱优势击败赛诺菲(SNY.US)，以73亿美元收购Reata Pharmaceuticals(RETA.US)。上周五，一份监管文件显...
2023-08-16 17:06
